Skip to main content
Log in

Expression of bone morphogenetic proteins 4, 6 and 7 is downregulated in kidney allografts with interstitial fibrosis and tubular atrophy

  • Nephrology - Original Paper
  • Published:
International Urology and Nephrology Aims and scope Submit manuscript

Abstract

Purpose

Bone morphogenetic proteins (BMPs) are pleiotropic growth factors. This paper investigates the connection between the expression pattern of BMPs in kidney allograft tissue versus the cause of allograft dysfunction.

Methods

The expression pattern of BMP2, BMP4, BMP6 and BMP7 in 50 kidney allografts obtained by transplant nephrectomy is investigated. Immunohistochemical staining is semiquantitatively evaluated for intensity to identify the expression pattern of BMPs in normal and allograft kidney tissues.

Results

The expression of BMP4 is unique between different tubular cell types in grafts without signs of fibrosis. This effect is not found in specimens with high grades of interstitial fibrosis and tubular atrophy (IFTA). In samples with IFTA grades II and III, the BMP7 expression is reduced in a significant fraction of specimens relative to those without signs of IFTA. The expression pattern of BMP6 indicates that its activation may be triggered by the act of transplantation and subsequent reperfusion injury. The expression of BMP2 is strong in all types of tubular epithelial cells and does not differ between the compared allografts and control kidney specimens.

Conclusion

The intensity and expression pattern of BMP4, BMP6 and BMP7 in transplanted kidney tissue are found to be dependent upon the length of the transplanted period, the clinical indication for transplant nephrectomy and signs of IFTA in kidney tissue.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Kingsley DM (1994) The TGF-beta superfamily: new members, new receptors, and new genetic tests of function in different organisms. Genes Dev 8:133–146

    Article  CAS  PubMed  Google Scholar 

  2. Hogan BLM (1996) Bone morphogenetic proteins in development. Curr Opin Genet Dev 6:432–438

    Article  CAS  PubMed  Google Scholar 

  3. Tyler JR, Robertson TA, Booth AD, Burt AD, Kirby JA (2006) Chronic allograft nephropathy: intraepithelial signals generated by transforming growth factor-β and bone morphogenetic protein-7. Am J Transplant 6:1367–1376

    Article  CAS  PubMed  Google Scholar 

  4. Solez K, Colvin RB, Racusen LC (2008) Banff 07 classification of renal allograft pathology: updates and future directions. Am J Transplant 8:753–760

    Article  CAS  PubMed  Google Scholar 

  5. Yang YL, Liu YS, Chuang LY et al (2009) Bone morphogenetic protein-2 antagonizes renal interstitial fibrosis by promoting catabolism of type I transforming growth factor-beta receptors. Endocrinology 150:727–740

    Article  CAS  PubMed  Google Scholar 

  6. Yamasaki M, Nomura T, Mimata H, Nomura Y (2004) Involvement of bone morphogenetic protein 2 in ossification of renal cell carcinoma. J Urol 172:475–476

    Article  PubMed  Google Scholar 

  7. Dudley AT, Robertson EJ (1997) Overlapping expression domains of bone morphogenetic protein family members potentially account for limited tissue defects in BMP7 deficient embryos. Dev Dyn 208:349–362

    Article  CAS  PubMed  Google Scholar 

  8. Miyazaki Y, Oshima K, Fogo A, Hogan BL, Ichikawa I (2000) Bone morphogenetic protein 4 regulates the budding site and elongation of the mouse uretere. J Clin Invest 105:863–873

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  9. Brenner-Anantharam A, Cebrian C, Guillaume R, Hurtado R, Sun TT, Herzlinger D (2007) Tailbud-derived mesenchyme promotes urinary tract segmentation via BMP4 signaling. Development 134(10):1967–1975

    Article  CAS  PubMed  Google Scholar 

  10. Tabatabaeifar M, Schlingmann KP, Litwin M et al (2009) Functional analysis of BMP4 mutations identified in pediatric CAKUT patients. Pediatr Nephrol 24(12):2361–2368

    Article  PubMed  Google Scholar 

  11. Dos Reis GS, Simoes E, Silva AC, Freitas IS, Heilbuth TR, de Marco LA, Oliveira EA, Miranda DM (2014) Study of the association between the BMP4 gene and congenital anomalies of the kidney and urinary tract. J Pediatr (Rio J) 90:58–64

    Article  Google Scholar 

  12. Oosterlee A, Rahmel A (2011) Eurotransplant International Foundation, Annual Report 2011. CIP-Gegevens Koniklijke bibliotheek, Den Haag 1–116

  13. Pascual M, Theruvath T, Kawai T, Tolkoff-Rubin N, Cosimi AB (2002) Strategies to improve long-term outcomes after renal transplantation. N Engl J Med 346:580–590

    Article  PubMed  Google Scholar 

  14. Basic-Jukic N, Radic-Antolic M, Hudolin T et al (2009) Immunolocalization and mRNA expression of bone morphogenetic protein-6 in human clear cell renal carcinoma. Kidney Blood Press Res 32:445–450

    Article  CAS  PubMed  Google Scholar 

  15. Dendooven A, van Oostrom O, van der Giezen DM et al (2011) Loss of endogenous bone morphogenetic protein-6 aggravates renal fibrosis. Am J Pathol 178:1069–1079

    Article  PubMed Central  PubMed  Google Scholar 

  16. Wang Y, Chang CF (2001) Morales M Bone morphogenetic protein-6 reduces ischemia-induced brain damage in rats. Stroke 32:2170–2178

    Article  CAS  PubMed  Google Scholar 

  17. Wetzel P, Haag J, Campean V et al (2006) Bone morphogenetic protein-7 expression and activity in the human normal kidney is predominantly localized to the distal nephron. Kidney Int 70:717–723

    Article  CAS  PubMed  Google Scholar 

  18. Mitu GM, Wang S, Hirschberg R (2007) BMP7 is a podocyte survival factor and rescues podocytes from diabetic injury. Am J Physiol Renal Physiol 293:2392–2399

    Article  Google Scholar 

  19. De Petris L, Hruska KA, Chiechio S, Liapis H (2007) Bone morphogenetic protein-7 delays podocyte injury due to high glucose. Nephrol Dial Transplant 22:3342–3450

    Article  Google Scholar 

  20. Dudley AT, Lyins KM, Robertson EJ (1995) A requirement for bone morphogenetic protein-7 during development of the mammalian kidney and eye. Genes Dev 9:2795–2807

    Article  CAS  PubMed  Google Scholar 

  21. Markić D, Celić T, Spanjol J et al (2010) Expression of bone morphogenetic protein-7, its receptors and Smad1/5/8 in normal human kidney and renal cell cancer. Coll Antropol 34(Suppl 2):149–153

    PubMed  Google Scholar 

  22. Gomez-Alamillo C, Ramos-Barron MA, Benito-Hernandez A, Rodrigo E, Ruiz JC, Agueros C, Sanchez M, Arias M (2012) Relation of urinary gene expression of epithelial-mesenchymal transition markers with initial events and 1-year graft function. Transplant Proc 44:2573–2576

    Article  CAS  PubMed  Google Scholar 

  23. Basic-Jukic N, Hudolin T, Radic-Antolic M et al (2011) Bone morphogenetic protein-7 expression is down-regulated in human clear cell renal carcinoma. J Nephrol 24:91–97

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

This study has been funded by a grant by the Croatian Ministry of science, education and sport. The authors of this manuscript have no conflicts of interest to disclose.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Vesna Furic-Cunko.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Furic-Cunko, V., Kes, P., Coric, M. et al. Expression of bone morphogenetic proteins 4, 6 and 7 is downregulated in kidney allografts with interstitial fibrosis and tubular atrophy. Int Urol Nephrol 47, 1219–1229 (2015). https://doi.org/10.1007/s11255-015-0993-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11255-015-0993-1

Keywords

Navigation